ActivEdge Platform
AI/AR/ML platform powering surgical innovation and intelligent visualization
Platform · EmbeddedCompany source
Company profile
About Activ Surgical
Provides Intraoperative Surgical Intelligence aimed at transforming healthcare standards and reducing complication rates through AI-enabled intraoperative visualization.
Company description Activ Surgical official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Work at Activ Surgical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Bariatric surgery
- Cholecystectomy
- Colorectal surgery
- Esophagectomy
- Thoracic/Foregut surgery
Who it serves
- Health Systems
- Hospitals
- Surgical Centers
Deployment & integration
Embedded deployment with recorded integration context.
Recorded integration context: Compatible with existing laparoscopic systems, Compatible with existing robotic surgical systems.
Geographic context
MarketsCE Mark regions · European Union · United States
Company sourceOfficial website
Company milestones
Platform expansion
CE Mark approval December 2022, first international procedure completed, over 200 patient procedures, FDA 510(k) clearance in 2021, multiple pilot hospital sites established
Partnerships
Recorded partners
- Children's National Medical Center
- Maastricht University Medical Center (MUMC+)
- Multiple major hospital networks across U.S. and Europe as pilot sites
- Northwell Health
- University of Cologne
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
ActivSight Intelligent Light
First modular multimodal advanced visualization system for minimally invasive surgery
Device · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Toward autonomous robotic-assisted and microrobotic surgery.Science advances · Jul 3, 2026
Dye-less quantification of tissue perfusion by laser speckle contrast imaging is equivalent to quantified indocyanine green in a porcine model.Surgical endoscopy · Oct 1, 2024
Clinical Utility of Laser Speckle Contrast Imaging and Real-Time Quantification of Bowel Perfusion in Minimally Invasive Left-Sided Colorectal Resections.Diseases of the colon and rectum · Jun 1, 2024
Real-time near infrared artificial intelligence using scalable non-expert crowdsourcing in colorectal surgery.NPJ digital medicine · Apr 22, 2024
Real-time First-In-Human Comparison of Laser Speckle Contrast Imaging and ICG in Minimally Invasive Colorectal & Bariatric Surgery.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · Dec 1, 2023
Dye-Less Perfusion Quantification of Porcine Gastric Conduit with Laser Speckle Contrast Imaging and Laser Doppler Imaging.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · Sep 1, 2023
Clinical validation
Clinical-trial records
A Prospective Study Assessing ActivSight Imaging for Intraoperative Perfusion Evaluation in Left-Sided ColectomyNCT07453797 · Sponsor · NOT YET RECRUITING
Safety and Feasibility of ActivSight(tm) in the Identification of The Ureter Via Riboflavin FluorescenceNCT06535555 · Sponsor · WITHDRAWN
Safety and Feasibility of ActivSightTM in HumanNCT04633512 · Sponsor · UNKNOWN
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in HumansNCT05591053 · Sponsor · UNKNOWN
Feasibility and Utility of Artificial Intelligence (AI) / Machine Learning (ML) - Driven Advanced Intraoperative Visualization and Identification of Critical Anatomic Structures and Procedural Phases in Laparoscopic CholecystectomyNCT05775133 · Sponsor · UNKNOWN
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Colorectal surgery leak rates up to 15%
$30,000+ cost per leak, 12 days additional length of stay
Bariatric surgery leak rates up to 8%
$66,000 per leak, 15 days additional length of stay
Esophagectomy leak rates of 20%
12-25% readmission rate, 7-73 days additional length of stay
400,000+ deaths annually due to avoidable complications in U.S.
26% of all medical errors are preventable surgical errors
$36B+ global cost for preventable medical errors
Preventable medical errors are 3rd leading cause of death
Maastricht University Medical Center (MUMC+)
Advanced visualization during surgery to reduce surgical complications
Seamless integration enabling advanced visualization capabilities
Multiple major hospital networks (US and Europe)
Pilot implementation of ActivSight for clinical validation
Over 200 patients treated successfully across multiple IRB studies
University of Cologne
Enhanced surgical vision to reduce unintended medical errors
Improved surgical outcomes through enhanced visualization
Northwell Health
Real-time blood supply visualization for surgical decision-making
Reproducible real-time blood supply assessment enabling reliable surgical decisions
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Activ Surgical
Recent articles published on Activ Surgical's official website.
Activ Surgical Announces Completion of First International Procedure Using Its ActivSight™ Intelligent Light
Read on Activ SurgicalActiv Surgical Appoints Manisha Shah-Bugaj as Chief Executive Officer
Read on Activ SurgicalActiv Surgical Announces Completion of First AI-Enabled Case Using Its ActivSight™Intelligent Light
Read on Activ SurgicalDye-Less Perfusion Quantification of Porcine Gastric Conduit with Laser Speckle Contrast Imaging and Laser Doppler Imaging
Read on Activ SurgicalActiv Surgical Publishes Whitepaper Demonstrating ActivSight™ Colorectal AI Mode
Read on Activ Surgical07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.